1. Home
  2. WOR vs BEAM Comparison

WOR vs BEAM Comparison

Compare WOR & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

HOLD

Current Price

$56.74

Market Cap

2.8B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$29.54

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOR
BEAM
Founded
1955
2017
Country
United States
United States
Employees
3400
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
WOR
BEAM
Price
$56.74
$29.54
Analyst Decision
Hold
Buy
Analyst Count
2
12
Target Price
$59.50
$50.75
AVG Volume (30 Days)
133.1K
1.8M
Earning Date
03-24-2026
05-06-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
82.31
EPS
2.17
N/A
Revenue
$1,153,762,000.00
$24,000.00
Revenue This Year
$22.21
N/A
Revenue Next Year
$6.03
$33.77
P/E Ratio
$26.70
N/A
Revenue Growth
N/A
33.33
52 Week Low
$45.01
$15.60
52 Week High
$70.91
$36.44

Technical Indicators

Market Signals
Indicator
WOR
BEAM
Relative Strength Index (RSI) 58.31 47.89
Support Level $51.93 $28.50
Resistance Level $58.56 $33.15
Average True Range (ATR) 1.47 2.05
MACD 0.20 -0.01
Stochastic Oscillator 77.52 40.12

Price Performance

Historical Comparison
WOR
BEAM

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: